BioSpace News Archive

Melior Pharmaceuticals is pleased to announce that it has randomized the last patient into its Phase 2b study for subjects with uncontrolled Type 2 diabetes on metformin therapy.

St. Mary’s Villa Unveils TripleCare’s Physician-based Telemedicine Service; Facility Now Offers Physician Access 24x7

Advancing the science of care measurement to drive savings and quality

Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., announces today that 5 poster presentations reporting new research on human genetics guided drug discovery will be highlighted at the American Society of Human Genetics (ASHG) Conference 2018, in San Diego from Oct 16-20, 2018.

DNAnexus today announced DNAnexus Apollo, an enhanced platform for clinico-genomic data science exploration, analysis, and discovery.

Kala Pharmaceuticals (Kala) (NASDAQ:KALA), today announced that it has submitted a New Drug Application (NDA) to the Food and Drug Administration (FDA) for KPI-121 0.25%, a topical product candidate which, if approved, could be the first FDA-approved product for the temporary relief of signs and symptoms of dry eye disease.

Asuragen, Inc., a molecular diagnostics company delivering easy-to-use products for complex testing in genetics and oncology, today announced that it has hired Tom Copa as senior vice president, commercial operations.

India Globalization Capital, Inc. announces financial results for the quarter ended September 30, 2018, which is the second quarter of its 2019 fiscal year.

New open-source cloud-based tool rapidly interprets terabytes of data to detect disease-causing pathogens

Steadfast Adoption and Fully Realized Capabilities Affirm Clinical Usability